La Trobe

Galanin receptor agonists limit osteoclast number in in vitro mouse models

journal contribution
posted on 2025-05-28, 05:30 authored by Heath McGowanHeath McGowan, Deanna HorvathDeanna Horvath, Amy LarsenAmy Larsen, Aaron McDonaldAaron McDonald

Despite evidence that galanin-like compounds are potential regulators of bone activity, little research has been undertaken to investigate the role of these compounds on osseous cells. The aim of this study was to elucidate the mechanisms by which the galanin receptor agonist’s galanin and galnon regulate osteoclasts. Osteoclasts were cultured from cells isolated from femurs of C57BL/6 mice and grown to 80% confluence, then differentiated via the application of mCSF and RANKL. Cultures were analyzed for osteoclast number via TRAP staining, qPCR and immunocytochemistry. A moderate dose of both galanin-like compounds decreased osteoclast count in vitro. The moderate dose of galanin also reduced expression of inflammatory markers. These results indicate that both galanin and galnon can act to reduce osteoclast count, although they have led to contradictory responses with respect to inflammatory expression. These results may help to better treatment for bone-resorptive diseases such as osteoporosis.

Funding

This project was supported by a grant from the Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University.

History

Publication Date

2025-03-31

Journal

Fortune Journal of Rheumatology

Volume

7

Issue

1

Pagination

7-19

Publisher

Fortune Journals

ISSN

2688-6766

Rights Statement

© The Authors 2025 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license 4.0

Usage metrics

    Journal Articles

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC